Improving Lives by Supporting
Biotherapeutic Innovations
SARS-COV-2 / Covid19 Testing. Check out Texcell’s offer here.
Texcell is a contract research organization that specializes in virus testings, viral clearance and safety, immunoprofiling, R&D and GMP cell banking, for your R&D, GClP, GLP and GMP applications.
Company News
Mar
06
5 Questions with Akunna Iheanacho, Ph.D., Scientific Director, Texcell North America, Inc.
“5 Questions With…” is a weekly BioBuzz series where they connect with interesting people in the BioHealth Capital Region to share a little about themselves, their work, and maybe something...
Oct
27
Panasonic Texcell collaboration on virucidal effect testing
Panasonic has announced that Texcell has verified the inhibitory effect of nanoe™ X, technology with the benefits of hydroxyl radicals on novel coronavirus (SARS-CoV-2). Learn more here.
Company Events
Mar
10
Biotesting Day: March 11-19 (virtual event)
Meet Texcell at The Polepharma Biotesting Days, an event for analytical strategies to accelerate the development of biotherapeutics.
Mar
06
Gene Therapy for Rare Disorders-February 23-25, 2021
Join us (virtually) for the 4th Annual Gene Therapy for Rare Disorders with programs that focus exclusively on overcoming the late-stage commercial challenges drug developers face delivering gene...